Sakar Healthcare Share Price
Start SIP in Sakar Healthcare
Start SIPSakar Healthcare Performance
Day Range
- Low 326
- High 338
52 Week Range
- Low 295
- High 479
- Open Price337
- Previous Close335
- Volume10794
Sakar Healthcare Investment Rating
-
Master Rating:
-
Sakar Healthcare has an operating revenue of Rs. 155.51 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 10% is healthy, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 21%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 16 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 13 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 41 | 43 | 37 | 34 | 39 | 41 |
| Operating Expenses Qtr Cr | 30 | 32 | 28 | 25 | 30 | 33 |
| Operating Profit Qtr Cr | 11 | 11 | 9 | 9 | 9 | 8 |
| Depreciation Qtr Cr | 5 | 5 | 4 | 4 | 5 | 4 |
| Interest Qtr Cr | 1 | 2 | 2 | 2 | 2 | 2 |
| Tax Qtr Cr | 2 | 2 | 1 | 1 | 1 | 0 |
| Net Profit Qtr Cr | 2 | 3 | 2 | 4 | 3 | 4 |
Sakar Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 6
- Bearish Moving Average
- ___
- 10
- 20 Day
- ₹325.38
- 50 Day
- ₹324.43
- 100 Day
- ₹331.54
- 200 Day
- ₹336.15
- 20 Day
- ₹322.08
- 50 Day
- ₹324.16
- 100 Day
- ₹328.06
- 200 Day
- ₹358.32
Sakar Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 334.43 |
| Second Resistance | 341.72 |
| Third Resistance | 345.93 |
| RSI | 52.15 |
| MFI | 66.10 |
| MACD Single Line | 2.37 |
| MACD | 4.07 |
| Support | |
|---|---|
| First Support | 322.93 |
| Second Support | 318.72 |
| Third Supoort | 311.43 |
Sakar Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 10,794 | 731,078 | 67.73 |
| Week | 36,845 | 1,779,992 | 48.31 |
| 1 Month | 28,144 | 1,767,457 | 62.8 |
| 6 Month | 23,270 | 1,274,041 | 54.75 |
Sakar Healthcare Result Highlights
Sakar Healthcare Synopsis
NSE-Medical-Ethical Drugs
Sakar Healthcare is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 153.35 Cr. and Equity Capital is Rs. 21.75 Cr. for the Year ended 31/03/2024. Sakar Healthcare Ltd. is a Public Limited Listed company incorporated on 26/03/2004 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2004PLC043861 and registration number is 043861.| Market Cap | 715 |
| Sales | 156 |
| Shares in Float | 1.00 |
| No of funds | 3 |
| Yield |
| Book Value | 2.77 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | 21 |
| Alpha | -0.1 |
| Beta | 1.08 |
Sakar Healthcare Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 53.15% | 53.15% | 53.15% | 54.15% |
| Mutual Funds | ||||
| Insurance Companies | ||||
| Foreign Portfolio Investors | 13.52% | 13.52% | 13.76% | 14.03% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 16.79% | 16.78% | 16.62% | 16.37% |
| Others | 16.54% | 16.55% | 16.47% | 15.45% |
Sakar Healthcare Management
| Name | Designation |
|---|---|
| Mr. Sanjay S Shah | Chairman & Managing Director |
| Mr. Aarsh S Shah | Joint Managing Director |
| Mr. Sunil Marathe | Whole Time Director - Technical |
| Ms. Vishalakshi Chandramouli | Non Executive Director |
| Ms. Rita S Shah | Non Executive Director |
| Mr. Hemendra C Shah | Independent Director |
| Mr. Shailesh B Patel | Independent Director |
| Mr. Prashant C Srivastav | Independent Director |
| Mr. Jignesh Parikh | Independent Director |
| Mrs. Khyati Shah | Independent Director |
Sakar Healthcare Forecast
Price Estimates
Sakar Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-13 | Quarterly Results | |
| 2024-05-21 | Audited results | |
| 2024-02-10 | Quarterly Results | |
| 2023-11-06 | Quarterly Results | |
| 2023-05-26 | Audited results |
Sakar Healthcare FAQs
What is Share Price of Sakar Healthcare ?
Sakar Healthcare share price is ₹327 As on 18 September, 2024 | 02:23
What is the Market Cap of Sakar Healthcare ?
The Market Cap of Sakar Healthcare is ₹698.5 Cr As on 18 September, 2024 | 02:23
What is the P/E ratio of Sakar Healthcare ?
The P/E ratio of Sakar Healthcare is 62.1 As on 18 September, 2024 | 02:23
What is the PB ratio of Sakar Healthcare ?
The PB ratio of Sakar Healthcare is 2.7 As on 18 September, 2024 | 02:23